Search results
Does the Anti-Inflammatory Diet for Psoriasis Help Manage Symptoms?
Verywell Health via Yahoo News· 3 days agoInflammation is one of the underlying causes of psoriasis, and research shows that an...
What Are the Most Effective Psoriasis Therapy Options?
Verywell Health via Yahoo News· 2 days agoWith many treatment options for psoriasis, how do you know which ones are right for you? Here are...
SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Ventyx...
FOX21 Colorado Springs· 5 days agoPomerantz LLP announces that a class action lawsuit has been filed against Ventyx Biosciences, Inc. ("Ventyx" or the "Company") (NASDAQ: VTYX) and certain officers. The class action, filed in ...
FDA Approval of Alvotech/Teva Ustekinumab Biosimilar | JD Supra
JD Supra· 2 days agoOn April 16, Alvotech and Teva announced the FDA approval of SELARSDI™ (ustekinumab-aekn), biosimilar to Johnson and Johnson’s STELERA® (ustekinumab). The product was approved as a subcutaneous ...
Johnson & Johnson (NYSE:JNJ) Shares Down 0.1%
ETF DAILY NEWS· 7 hours agoJohnson & Johnson (NYSE:JNJ – Get Free Report) traded down 0.1% during mid-day trading on Tuesday . Raymond James upped their price objective on shares of Johnson & Johnson from $172.00 to $175.00 ...
AbbVie (ABBV) to Release Quarterly Earnings on Friday
ETF DAILY NEWS· 12 hours agoAbbVie (NYSE:ABBV – Get Free Report) is scheduled to be issuing its quarterly earnings data before the market opens on Friday, April 26th. Analysts expect the company to announce earnings of ...
VTYX IMPORTANT DEADLINE: ROSEN, TRUSTED INVESTOR COUNSEL, Encourages Ventyx Biosciences, Inc....
WPRI Providence· 4 days agoWHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of Ventyx Biosciences, Inc. (NASDAQ: VTYX): (i) pursuant and/or traceable to the offering documents ...
Colton Groome Financial Advisors LLC Raises Stock Position in Johnson & Johnson (NYSE:JNJ)
ETF DAILY NEWS· 9 hours agoColton Groome Financial Advisors LLC boosted its position in shares of Johnson & Johnson (NYSE:JNJ – Free Report) by 32.6% in the 4th quarter, according to the company in its most recent Form ...
Financial Symmetry Inc Takes $207,000 Position in Johnson & Johnson (NYSE:JNJ)
ETF DAILY NEWS· 9 hours agoFinancial Symmetry Inc bought a new stake in Johnson & Johnson (NYSE:JNJ – Free Report) during the fourth quarter, according to the company in its most recent filing with the Securities and ...
Novartis (NVS) Q1 Earnings, Sales Beat, Guidance Raised
Zacks via Yahoo Finance· 2 days agoCosentyx’s sales (psoriasis, spondylitis, arthritis) increased 25% to $1.3 billion, beating the...
